blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2220116

EP2220116 - COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.07.2013
Database last updated on 18.09.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Theraclone Sciences, Inc.
1124 Columbia Street, Suite 300
Seattle, WA 98104 / US
[2010/52]
Former [2010/34]For all designated states
Spaltudaq Corporation
1124 Columbia Street Suite 300
Seattle, WA 98104 / US
Inventor(s)01 / GRANDEA, Andres, G.
1124 Columbia Street
Suite 300
Seattle WA 98104 / US
02 / KING, Gordon
1124 Columbia Street
Suite 300
Seattle WA 98104 / US
03 / COX, Thomas
1124 Columbia Street
Suite 300
Seattle WA 98104 / US
04 / OLSEN, Ole
1124 Columbia Street
Suite 300
Seattle WA 98104 / US
05 / MITCHAM, Jennifer
1124 Columbia Street
Suite 300
Seattle WA 98104 / US
06 / MOYLE, Matthew
15737 NE 134th Street
Redmond, Washington 98052 / US
 [2012/36]
Former [2010/51]01 / GRANDEA, Andres, G.
1124 Columbia Street Suite 300
Seattle WA 98104 / US
02 / KING, Gordon
1124 Columbia Street Suite 300
Seattle WA 98104 / US
03 / COX, Thomas
1124 Columbia Street Suite 300
Seattle WA 98104 / US
04 / OLSEN, Ole
1124 Columbia Street Suite 300
Seattle WA 98104 / US
05 / MITCHAM, Jennifer
1124 Columbia Street Suite 300
Seattle WA 98104 / US
06 / MOYLE, Matthew
15737 NE 134th Street
Redmond, Washington 98052 / US
Former [2010/34]01 / GRANDEA, Andres, G.
1124 Columbia Street Suite 300
Seattle WA 98104 / US
02 / KING, Gordon
1124 Columbia Street Suite 300
Seattle WA 98104 / US
03 / COX, Thomas
1124 Columbia Street Suite 300
Seattle WA 98104 / US
04 / OLSEN, Ole
1124 Columbia Street Suite 300
Seattle WA 98104 / US
05 / MITCHAM, Jennifer
1124 Columbia Street Suite 300
Seattle WA 98104 / US
Representative(s)Mintz Levin Cohn Ferris Glovsky and Popeo LLP
Alder Castle
10 Noble Street
London EC2V 7JX / GB
[2013/15]
Former [2012/36]Clarke, Victoria
Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP Alder Castle 10 Noble Street
London EC2V 7JX / GB
Former [2010/34]Clarke, Victoria
Mintz Levin Cohn Ferris Glovsky and Popeo Intellectual Property LLP Alder Castle 10 Noble Street
London EC2V 7JX / GB
Application number, filing date08850112.712.11.2008
[2010/34]
WO2008US83265
Priority number, dateUS20070987355P12.11.2007         Original published format: US 987355 P
US20070987353P12.11.2007         Original published format: US 987353 P
US20080053840P16.05.2008         Original published format: US 53840 P
US20080095208P08.09.2008         Original published format: US 95208 P
[2010/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009064805
Date:22.05.2009
Language:EN
[2009/21]
Type: A1 Application with search report 
No.:EP2220116
Date:25.08.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 22.05.2009 takes the place of the publication of the European patent application.
[2010/34]
Type: B1 Patent specification 
No.:EP2220116
Date:05.09.2012
Language:EN
[2012/36]
Search report(s)International search report - published on:EP22.05.2009
ClassificationIPC:C07K16/10, G01N33/569, A61K39/395, A61P31/16, C07K14/11
[2010/34]
CPC:
C07K16/1018 (EP,KR,US); A61P31/16 (EP); A61P37/02 (EP);
A61P43/00 (EP); C07K14/005 (EP,KR,US); G01N33/56983 (EP,KR,US);
A61K2039/505 (EP,KR,US); C07K2317/21 (EP,US); C07K2317/32 (EP,US);
C07K2317/34 (EP,US); C12N2760/16122 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/34]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR THERAPIE UND DIAGNOSE VON GRIPPE[2010/34]
English:COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF INFLUENZA[2010/34]
French:COMPOSITIONS ET PROCÉDÉS POUR TRAITER ET DIAGNOSTIQUER LA GRIPPE[2010/34]
Entry into regional phase11.06.2010National basic fee paid 
11.06.2010Designation fee(s) paid 
11.06.2010Examination fee paid 
Examination procedure11.06.2010Examination requested  [2010/34]
02.08.2010Amendment by applicant (claims and/or description)
13.10.2010Despatch of a communication from the examining division (Time limit: M06)
20.04.2011Reply to a communication from the examining division
13.07.2011Despatch of a communication from the examining division (Time limit: M04)
11.11.2011Reply to a communication from the examining division
17.04.2012Communication of intention to grant the patent
25.07.2012Fee for grant paid
25.07.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  13.10.2010
Opposition(s)06.06.2013No opposition filed within time limit [2013/33]
Fees paidRenewal fee
24.11.2010Renewal fee patent year 03
23.11.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.11.2008
CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
MT05.09.2012
PL05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
TR05.09.2012
LU12.11.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
[2014/34]
Former [2014/27]CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
MT05.09.2012
PL05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
TR05.09.2012
LU12.11.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
Former [2014/21]CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
MT05.09.2012
PL05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
TR05.09.2012
MC30.11.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
Former [2013/51]CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
MT05.09.2012
PL05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
Former [2013/34]CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
BG05.12.2012
GR06.12.2012
IS05.01.2013
Former [2013/23]CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
PL05.09.2012
RO05.09.2012
SI05.09.2012
SK05.09.2012
GR06.12.2012
IS05.01.2013
Former [2013/22]CY05.09.2012
CZ05.09.2012
EE05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
SI05.09.2012
GR06.12.2012
IS05.01.2013
Former [2013/11]CY05.09.2012
HR05.09.2012
LT05.09.2012
LV05.09.2012
SI05.09.2012
GR06.12.2012
Former [2013/10]CY05.09.2012
HR05.09.2012
LT05.09.2012
Former [2013/08]LT05.09.2012
Cited inInternational search[X]WO2006061723  (KIRIN BREWERY [JP], et al) [X] 1,2,4-9,24-41 * examples 1-6 *;
 [A]WO2007031550  (CRUCELL HOLLAND BV [NL], et al) [A] 1-9,14-41 * examples 1-5 *;
 [X]  - FENG JINGQI ET AL, "Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2", VIROLOGY JOURNAL, BIOMED CENTRAL, LONDON, GB, (20061206), vol. 3, no. 1, ISSN 1743-422X, page 102, XP021025427 [X] 1-9,14-41 * the whole document * * page 106 - page 109 *

DOI:   http://dx.doi.org/10.1186/1743-422X-3-102
 [A]  - ZHANG M ET AL, "Fine specificity and sequence of antibodies directed against the ectodomain of matrix protein 2 of influenza A virus", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 43, no. 14, ISSN 0161-5890, (20060701), pages 2195 - 2206, (20060701), XP025037291 [A] 1-9,14-41 * page 2203 - page 2204 *

DOI:   http://dx.doi.org/10.1016/j.molimm.2005.12.015
 [PX]  - DE FILETTE MARINA ET AL, "An influenza A vaccine based on tetrameric ectodomain of matrix protein 2.", THE JOURNAL OF BIOLOGICAL CHEMISTRY 25 APR 2008, (20080425), vol. 283, no. 17, ISSN 0021-9258, pages 11382 - 11387, XP002518513 [PX] 1-9,24-41 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.m800650200
by applicantUS3773919
 EP0183070
 US4683202
 EP0244234
 US4816567
 DD266710
 WO9013646
 EP0402226
 US5053394
 WO9202551
 US5229275
 WO9321232
 WO9411026
 WO9607321
 US5545806
 US5545807
 US5567610
 US5569825
 US5591669
 US5627052
 WO9717852
 US5648237
 US5739116
 US5767285
 US5770701
 US5770710
 US5773001
 US5789199
 US5840523
 US5877296
 US6331415
 US6824780
 US7112439
    - JAKOBOVITS ET AL., PROC. NATL. ACAD. SCI. USA, (1993), vol. 90, page 2551
    - JAKOBOVITS ET AL., NATURE, (1993), vol. 362, pages 255 - 258
    - BRUGGEMANN ET AL., YEAR IN IMMUNO., (1993), vol. 7, page 33
    - GABIZON ET AL., J. NATIONAL CANCER INST., (1989), vol. 81, no. 19, page 1484
    - "The value of a database in surveillance and vaccine selection", MACKEN ET AL., Options for the Control ofInfluenza IV. A.D.M.E., ELSEVIER SCIENCE, (2001), pages 103 - 106
    - BABCOOK ET AL., PROC. NATL. ACAD. SCI. USA, (1996), vol. 93, pages 7843 - 48
    - PLUCKTHUN ET AL., METHODS ENZYMOL., (1989), vol. 178, pages 497 - 515
    - SANGER ET AL., PROC. NATL. ACAD. SCI. USA, (1977), vol. 74, page 5463
    - BIRD ET AL., SCIENCE, (1988), vol. 242, pages 423 - 426
    - YANIV, NATURE, (1982), vol. 297, pages 17 - 18
    - GRAHAM ET AL., J. GEN VIROL., (1977), vol. 36, page 59
    - URLAUB ET AL., PROC. NATL. ACAD. SCI. USA, (1980), vol. 77, page 4216
    - MATHER, BIOL. REPROD., (1980), vol. 23, pages 243 - 251
    - MATHER ET AL., ANNALS N.Y. ACAD. SCI., (1982), vol. 383, pages 44 - 68
    - MADDOX, D. ET AL., J. EXP. MED., (1983), vol. 158, pages 1211 - 1216
    - PORATH, J. ET AL., PROT. EXP. PURIF., (1992), vol. 3, pages 263 - 281
    - KROLL, D. J. ET AL., DNA CELL BIOL., (1993), vol. 12, pages 441 - 453
    - CARTER ET AL., BIO/TECHNOLOGY, (1992), vol. 10, pages 163 - 167
    - LINDMARK ET AL., J. IMMUNOL. METH., (1983), vol. 62, pages 1 - 13
    - GUSS ET AL., EMBO J., (1986), vol. 5, page 15671575
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.